MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells
Open Access
- 22 July 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (35) , 58072-58085
Abstract
MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cellsKeywords
This publication has 40 references indexed in Scilit:
- Chinese herbal drugs for the treatment of diabetic retinopathyJournal of Pharmacy and Pharmacology, 2017
- Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in miceCanadian Journal of Physiology and Pharmacology, 2016
- Ginsenosides and their metabolites: a review of their pharmacological activities in the skinArchives of Dermatological Research, 2015
- MicroRNAs in B-cell lymphomas: how a complex biology gets more complexLeukemia, 2014
- Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced AgingPLOS ONE, 2014
- Novel Peptide-Specific Quantitative Structure–Activity Relationship (QSAR) Analysis Applied to Collagen IV Peptides with Antiangiogenic ActivityJournal of Medicinal Chemistry, 2011
- Rb regulates fate choice and lineage commitment in vivoNature, 2010
- Ginseng Compounds: An Update on their Molecular Mechanisms and Medical ApplicationsCurrent Vascular Pharmacology, 2009
- Insights from Angiogenesis Trials Using Fibroblast Growth Factor for Advanced Arteriosclerotic DiseaseTrends in Cardiovascular Medicine, 2003
- Brief Introduction of Panax ginseng C.A. MeyerJournal of Korean Medical Science, 2001